For intervention and comparison: SGLT-2 Inhibitor OR SGLT-2 Inhibitors OR Sodium-Glucose Transporter 2 Inhibitors OR canagliflozin OR empagliflozin OR dapagliflozin OR ipragliflozin OR luseogliflozin OR tofogliflozin OR remogliflozin OR sergliflozin OR sotagliflozin OR ertugliflozin OR GLP-1 receptor agonist OR GLP-1 receptor agonists OR glucagon like peptide 1 receptor agonist OR GLP-1 agonists OR exenatide OR liraglutide OR albiglutide OR lixisenatide OR semaglutide OR dulaglutide OR taspoglutide
Increased Fertility If a woman is living with obesity, this means there is likely also significant inflammation and potentially abnormal testosterone levels, says Szoke, adding that obesity can affect ovulation and menstrual cycles, as well
Patients with diabetes or prediabetes should monitor blood glucose closely Theoretical cancer concern: improved IGF-1 has been associated with certain cancer risks in epidemiological studies
Frequently Asked Questions What happens if I stop taking Zepbound
However, the full understanding of the absorption, distribution, metabolism, and excretion (ADME) processes is not feasible
Why Muscle Loss Matters in GLP-1 Therapy Muscle tissue plays a central role in metabolic stability, mobility, and healthy aging